Drug-Induced Death Signaling Strategy Rapidly Predicts Cancer Response to ChemotherapyJoan Montero, Anthony Letai, Kristopher A. Sarosiek et al.|Cell|2015Cited by 377
Herceptin in patients with advanced or metastatic salivary gland carcinomas. A phase II studyRobert I. Haddad, Marshall R. Posner, A. Dimitrios Colevas et al.|Oral Oncology|2003Cited by 262
HER2 Expression in Salivary Gland CarcinomasBonnie S. Glisson, Marshall R. Posner, A. Dimitrios Colevas et al.|Clinical Cancer Research|2004Cited by 202
Prospective serial evaluation of 2-hydroxyglutarate, during treatment of newly diagnosed acute myeloid leukemia, to assess disease activity and therapeutic responseAmir Fathi, Yi‐Bin Chen, Hossein Sadrzadeh et al.|Blood|2012Cited by 123
Presentation and outcomes among patients with isolated myeloid sarcoma: a Surveillance, Epidemiology, and End Results database analysisMaryam Movassaghian, Amir T. Fathi, Andrew M. Brunner et al.|Leukemia & lymphoma/Leukemia and lymphoma|2014Cited by 95